Skip to main content
Erschienen in: Journal of Cancer Survivorship 4/2014

01.12.2014

Survivorship Care Plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial

verfasst von: Nicole P. M. Ezendam, Kim A. H. Nicolaije, Roy F. P. M. Kruitwagen, Johanna M. A. Pijnenborg, M. Caroline Vos, Dorry Boll, Marjo van Bommel, Lonneke V. van de Poll-Franse

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study assesses the effect of sending a Survivorship Care Plan (SCP) to primary care physicians (PCP) on the communication of the PCP with the medical specialist and the patient and to describe PCPs’ opinions regarding the SCP.

Methods

In a pragmatic cluster randomized controlled trial conducted in 12 hospitals, the PCP of endometrial and ovarian cancer patients received usual information, while in addition the SCP-care arm received a copy of the patient’s SCP.

Results

A questionnaire was returned by 266 PCPs (76 %). One third of the PCPs in the SCP-care arm indicated having received an SCP. PCPs in the SCP-care arm were more likely to have had personal contact with the medical specialist (52 vs. 37 %, p = 0.01) but were equally satisfied with the information as PCPs in the usual care arm (7.2 vs. 6.9 on a scale from 1 to 10, p = 0.25). Of all PCPs, 82 % indicated they would want to receive an SCP in the future. A quarter of the PCPs who received an SCP reported that the SCP supported contact with the patient. However, the SCP was found too long.

Conclusions

Supplying an SCP to PCPs potentially has a positive effect on the communication between the PCP and the medical specialist. The SCP should be concise and focused on PCPs’ needs, such as contact information and tailored information on patient diagnosis, treatment, and possible consequences.

Implications for Cancer Survivors

In the light of transition of cancer care to PCPs, survivors may benefit from improved information provision and communication.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.CrossRefPubMed Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.CrossRefPubMed
2.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.CrossRefPubMed Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.CrossRefPubMed
3.
Zurück zum Zitat Cheung WY, Aziz N, Noone AM, Rowland JH, Potosky AL, Ayanian JZ, et al. Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv. 2013;7(3):343–54.CrossRefPubMed Cheung WY, Aziz N, Noone AM, Rowland JH, Potosky AL, Ayanian JZ, et al. Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv. 2013;7(3):343–54.CrossRefPubMed
4.
Zurück zum Zitat Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract Am Soc Clin Oncol. 2007;3(2):79–86.CrossRef Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract Am Soc Clin Oncol. 2007;3(2):79–86.CrossRef
5.
Zurück zum Zitat Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24(6):848–55.CrossRefPubMed Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24(6):848–55.CrossRefPubMed
6.
Zurück zum Zitat Nazorg bij kanker: de rol van de eerste lijn. KWF Kankerbestrijding2011. Nazorg bij kanker: de rol van de eerste lijn. KWF Kankerbestrijding2011.
7.
Zurück zum Zitat Lewis RA, Neal RD, Williams NH, France B, Hendry M, Russell D, et al. Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract. 2009;59(564):e234–47.PubMedCentralCrossRefPubMed Lewis RA, Neal RD, Williams NH, France B, Hendry M, Russell D, et al. Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract. 2009;59(564):e234–47.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24 Suppl 2:S459–66. doi:10.1007/s11606-009-1000-2.CrossRefPubMed Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24 Suppl 2:S459–66. doi:10.​1007/​s11606-009-1000-2.CrossRefPubMed
10.
Zurück zum Zitat Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26(5):759–67.CrossRefPubMed Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26(5):759–67.CrossRefPubMed
11.
Zurück zum Zitat Earle CC, Ganz PA. Cancer survivorship care: don’t let the perfect be the enemy of the good. J Clin Oncol. 2012;30(30):3764–8.CrossRefPubMed Earle CC, Ganz PA. Cancer survivorship care: don’t let the perfect be the enemy of the good. J Clin Oncol. 2012;30(30):3764–8.CrossRefPubMed
12.
Zurück zum Zitat Dicicco-Bloom B, Cunningham RS. The experience of information sharing among primary care clinicians with cancer survivors and their oncologists. J Cancer Surviv. 2012;7(1):124–30.CrossRefPubMed Dicicco-Bloom B, Cunningham RS. The experience of information sharing among primary care clinicians with cancer survivors and their oncologists. J Cancer Surviv. 2012;7(1):124–30.CrossRefPubMed
13.
Zurück zum Zitat Roorda C, Berendsen AJ, Haverkamp M, van der Meer K, de Bock GH. Discharge of breast cancer patients to primary care at the end of hospital follow-up: a cross-sectional survey. Eur J Cancer. 2013;49(8):1836–44.CrossRefPubMed Roorda C, Berendsen AJ, Haverkamp M, van der Meer K, de Bock GH. Discharge of breast cancer patients to primary care at the end of hospital follow-up: a cross-sectional survey. Eur J Cancer. 2013;49(8):1836–44.CrossRefPubMed
14.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2005. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2005.
15.
Zurück zum Zitat Shalom MM, Hahn EE, Casillas J, Ganz PA. Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract Am Soc Clin Oncol. 2011;7(5):314–8.CrossRef Shalom MM, Hahn EE, Casillas J, Ganz PA. Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract Am Soc Clin Oncol. 2011;7(5):314–8.CrossRef
16.
Zurück zum Zitat Mayer DK, Gerstel A, Leak AN, Smith SK. Patient and provider preferences for survivorship care plans. J Oncol Pract Am Soc Clin Oncol. 2012;8(4):e80–6.CrossRef Mayer DK, Gerstel A, Leak AN, Smith SK. Patient and provider preferences for survivorship care plans. J Oncol Pract Am Soc Clin Oncol. 2012;8(4):e80–6.CrossRef
17.
Zurück zum Zitat Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–62.CrossRefPubMed Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–62.CrossRefPubMed
18.
Zurück zum Zitat Smith SL, Wai ES, Alexander C, Singh-Carlson S. Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol (Toronto, Ont). 2011;18(5):e218–26. Smith SL, Wai ES, Alexander C, Singh-Carlson S. Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol (Toronto, Ont). 2011;18(5):e218–26.
19.
Zurück zum Zitat van de Poll-Franse LV, Nicolaije KA, Vos MC, Pijnenborg JM, Boll D, Husson O, et al. The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. Trials. 2011;12:256.PubMedCentralCrossRefPubMed van de Poll-Franse LV, Nicolaije KA, Vos MC, Pijnenborg JM, Boll D, Husson O, et al. The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. Trials. 2011;12:256.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Nicolaije KA, Ezendam NP, Vos MC, Pijnenborg JM, van de Poll-Franse LV, Kruitwagen RF. Oncology providers’ evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY Care trial. J Cancer Surviv. 2013. doi:10.1007/s11764-013-0327-1.PubMed Nicolaije KA, Ezendam NP, Vos MC, Pijnenborg JM, van de Poll-Franse LV, Kruitwagen RF. Oncology providers’ evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY Care trial. J Cancer Surviv. 2013. doi:10.​1007/​s11764-013-0327-1.PubMed
21.
Zurück zum Zitat Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer. 2008;113(4):870–8.CrossRefPubMed Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer. 2008;113(4):870–8.CrossRefPubMed
22.
Zurück zum Zitat Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27(20):3338–45.CrossRefPubMed Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27(20):3338–45.CrossRefPubMed
23.
Zurück zum Zitat Adams E, Boulton M, Rose P, Lund S, Richardson A, Wilson S, et al. Views of cancer care reviews in primary care: a qualitative study. Br J Gen Pract. 2011;61(585):173–82.CrossRefPubMed Adams E, Boulton M, Rose P, Lund S, Richardson A, Wilson S, et al. Views of cancer care reviews in primary care: a qualitative study. Br J Gen Pract. 2011;61(585):173–82.CrossRefPubMed
24.
Zurück zum Zitat Bober SL, Recklitis CJ, Campbell EG, Park ER, Kutner JS, Najita JS, et al. Caring for cancer survivors: a survey of primary care physicians. Cancer. 2009;115(18 Suppl):4409–18.CrossRefPubMed Bober SL, Recklitis CJ, Campbell EG, Park ER, Kutner JS, Najita JS, et al. Caring for cancer survivors: a survey of primary care physicians. Cancer. 2009;115(18 Suppl):4409–18.CrossRefPubMed
25.
Zurück zum Zitat Salz T, Oeffinger KC, Lewis PR, Williams RL, Rhyne RL, Yeazel MW. Primary care providers’ needs and preferences for information about colorectal cancer survivorship care. J Am Board Fam Med. 2012;25(5):635–51.PubMedCentralCrossRefPubMed Salz T, Oeffinger KC, Lewis PR, Williams RL, Rhyne RL, Yeazel MW. Primary care providers’ needs and preferences for information about colorectal cancer survivorship care. J Am Board Fam Med. 2012;25(5):635–51.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Watson EK, Sugden EM, Rose PW. Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey. J Cancer Surviv. 2010;4(2):159–66.CrossRefPubMed Watson EK, Sugden EM, Rose PW. Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey. J Cancer Surviv. 2010;4(2):159–66.CrossRefPubMed
Metadaten
Titel
Survivorship Care Plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial
verfasst von
Nicole P. M. Ezendam
Kim A. H. Nicolaije
Roy F. P. M. Kruitwagen
Johanna M. A. Pijnenborg
M. Caroline Vos
Dorry Boll
Marjo van Bommel
Lonneke V. van de Poll-Franse
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 4/2014
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0368-0

Weitere Artikel der Ausgabe 4/2014

Journal of Cancer Survivorship 4/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.